Filter
802
Filtered Results: 802
Text search:
National
systems
response
to
NCDs
Featured
Recommendations
69
New Publications
214
Language
Document type
No document type
340
Studies & Reports
251
Guidelines
91
Strategic & Response Plan
54
Manuals
40
Situation Updates
10
Fact sheets
8
Training Material
5
Resource Platforms
3
Countries / Regions
Global
84
Kenya
34
India
25
Malawi
23
South Africa
21
Rwanda
20
Liberia
18
Africa
18
Ukraine
17
Latin America and the Carribbean
17
Ethiopia
16
Uganda
16
Philippines
15
Zambia
15
Ghana
14
Western and Central Europe
14
Bangladesh
13
Myanmar / Burma
13
Nigeria
12
Namibia
12
South–East Asia Region
12
Nepal
11
Sierra Leone
10
Syria
10
Tanzania
9
Botswana
7
Lesotho
7
Asia
7
Zimbabwe
5
Cambodia
5
East and Southern Africa
5
Middle East and North Africa
5
Western Pacific Region
5
Eastern Europe
5
North America
5
Indonesia
4
Eswatini/ Swaziland
4
Brazil
4
Yemen
4
West and Central Africa
4
Moldova
4
South Sudan
3
Turkey
3
Thailand
3
Mozambique
3
Eastern Europe and Central Asia
3
Venezuela
3
Russia
3
Senegal
2
Congo, Democratic Republic of
2
Haiti
2
Pakistan
2
Lebanon
2
Sudan
2
Colombia
2
Mexico
2
Chile
2
Paraguay
2
Bulgaria
2
Kyrgyzstan
2
Guinea
1
USA
1
Saudi Arabia
1
Cameroon
1
Somalia
1
Iraq
1
Jordan
1
Afghanistan
1
Egypt
1
Chad
1
China
1
Benin
1
Argentina
1
Peru
1
North Macedonia
1
Hungary
1
Bolivia
1
Madagascar
1
Other region
1
Poland
1
Albania
1
Laos
1
Timor Leste/ East Timor
1
Tajikistan
1
Romania
1
Slovakia
1
Kazakhstan
1
Vietnam
1
Jamaica
1
Japan
1
Mauritius
1
United Kingdom
1
Portugal
1
Spain
1
Azerbaijan
1
Belarus
1
Israel
1
Authors & Publishers
Publication Years
Category
Countries
387
Public Health
156
Clinical Guidelines
71
Women & Child Health
25
Key Resources
16
Capacity Building
10
Pharmacy & Technologies
6
Toolboxes
NCDs
121
Mental Health
63
COVID-19
51
Planetary Health
50
Global Health Education
29
Conflict
24
HIV
23
Caregiver
21
Disability
14
TB
13
Refugee
9
Health Financing Toolbox
9
Natural Hazards
5
Pharmacy
4
Rapid Response
3
AMR
3
Ebola
1
Social Ethics
1
NTDs
1
Background
Cardiovascular diseases (CVDs) are one of the global leading causes of concern due to the rising prevalence and consequence of mortality and disability with a heavy economic burden. The objective of the current study was ... analyze the trend in CVD incidence, mortality, and mortality-to-incidence ratio (MIR) across the world over 28 years.
Methods
The age-standardized CVD mortality and incidence rates were retrieved from the Global Burden of Disease (GBD) Study 2017 for both genders and different world super regions with available data every year during the period 1990–2017. Additionally, the Human Development Index was sourced from the United Nations Development Programme (UNDP) database for all countries at the same time interval. The marginal modeling approach was implemented to evaluate the mean trend of CVD incidence, mortality, and MIR for 195 countries and separately for developing and developed countries and also clarify the relationship between the indices and Human Development Index (HDI) from 1990 to 2017.
Results
The obtained estimates identified that the global mean trend of CVD incidence had an ascending trend until 1996 followed by a descending trend after this year. Nearly all of the countries experienced a significant declining mortality trend from 1990 to 2017. Likewise, the global mean MIR rate had a significant trivial decrement trend with a gentle slope of 0.004 over the time interval. As such, the reduction in incidence and mortality rates for developed countries was significantly faster than developing counterparts in the period 1990–2017 (p < 0.05). Nevertheless, the developing nations had a more rather shallow decrease in MIR compared to developed ones.
Conclusions
Generally, the findings of this study revealed that there was an overall downward trend in CVD incidence and mortality rates, while the survival rate of CVD patients was rather stable. These results send a satisfactory message that global effort for controlling the CVD burden was quite successful. Nonetheless, there is an urgent need for more efforts to improve the survival rate of patients and lower the burden of this disease in some areas with an increasing trend of either incidence or mortality.
Key considerations for the use of law to prevent noncommunicable diseases in the WHO European Region
Report of an intensive legal training and capacity-building workshop on law and noncommunicable diseases (Moscow, 30 May–3 June 2016)
The report summarizes important issues, themes and topics discussed during the meeting in Moscow, ranging from the design and implementation of legislation, reconc...
Центр лечения тяжелых острых респираторных инфекцийПрактическое руководство по организации центра лечения ТОРИ ицентра проведения скрининга на ТОРИ на базе мед...
آذار / مارس 2020مركز معالجة حالات العدوى التنفسیة الحادة الوخیمةدلیل عملي لإنشاء وإدارة مركز لمعالجة حالات العدوى التنفسیة الحادة الوخیمة وقسم لتحري المصابین بھذه ا...
The workshop aimed to support countries in the prioritization and acceleration of NCD prevention and management with a specific focus on accelerating the prevention and control of hypertension and diabetes, identifying the most impactful NCD interve...
Diabetes is a significant public health issue that affects approximately one in 10 adults globally, with type 2 diabetes accounting for 90–95% of cases. This chronic condition causes considerable morbidity and mortality and is growing in impact, with cases projected ... rise from 537 million in 2021 to 784 million by 2045. As cases rise, it is imperative to ensure the healthcare workforce is prepared to care for affected individuals. However, there is a growing global shortage of healthcare workers, which was estimated, pre pandemic, to reach 15 million by 2030. Therefore, all of the healthcare workforce will need to be utilised to their fullest potential in order to address the growing global burden of diabetes. Pharmacists will continue to be essential in this endeavour.
Chronic kidney disease (CKD) is an important contributor to mortality from noncommunicable diseases. No decrease has been seen for CKD mortality contrary to many other important non-communicable dis...
Aerosol pollutants are known to raise the risk of development of non-communicable respiratory diseases (NCRDs) such as asthma, chronic bronchitis, chronic obstructive pulmonary disease, and allergic rhinitis. Sub-Saharan Africa’s rapid pace of urb...
The Mexico Declaration for Circulatory Health brings together global health
organizations committed to improving circulatory health and reducing deaths and disability from heart disease and stroke around the world. These diseases presently represen...
Asthma is the most common chronic respiratory disease (CRD) worldwide and is estimated to affect 262 million causing significant mortality and morbidity, and has emerged as an important public health problem in many Latin American (LA) countries ove...
Asthma is the most common non-communicable disease in children and remains one of the most common throughout the life course. The great majority of the burden of this disease is seen in low-income and middle-income countries (LMICs), which have disproportionately high asthma-related mortality relati...
Time has seen management for Cystic Fibrosis (CF) advance drastically, most recently in the development of the disease-modifying triple combination therapy ivacaftor/tezacaftor/elexacaftor. There is currently limited evidence regarding both the global epidemiology of CF and access ... this transformative therapy - and therefore where needs are not being met. Therefore, this study aims to define gaps in access to CF treatment. The results show that a significant CF patient burden exists in countries where disease-modifying drugs are unavailable, and final figures are likely underestimates. This analysis shows the potential to improve rates of diagnosis and treatment for CF, so a higher percentage of patients receive the most effective triple combination treatment.
Global progress against cardiovascular disease (CVD) is flatlining.
Though rates of CVD deaths globally have fallen in the last three
decades, this trend has begun to stall and, without concerted
efforts, is at risk of reversing.
Asthma is the most common chronic condition in children worldwide. It affects daytime activities, sleep and school attendance and causes anxiety to parents, families and other carers. The quality of asthma diagnosis and management globally still nee...
The World Heart Federation (WHF) is a leading global advocate for stronger legislation and policies regarding cardiovascular disease (CVD) and its risk factors, including raised cholesterol. The present Cholesterol Advocacy Toolkit 2022 provides WHF member organizations with information as well as p...
Asthma is one of the neglected diseases in Africa with a high prevalence. Allergic fungal diseases have been reported to complicate asthma progression and treatment outcomes. However, data about fungal asthma and its associated complications are lim...
The document, "Sustainable Management of Radiotherapy Facilities and Equipment," by WHO and IAEA, provides guidelines for managing radiotherapy equipment and facilities to ensure effective and safe cancer treatment. It covers essential aspects like ...
Asthma is the commonest chronic childhood disease and encompasses a spectrum of airway diseases with similar symptoms. Inaccurate diagnosis remains common, especially in younger children, with failure to characterize the different “asthmas.” Chi...
The European Respiratory Society (ERS)/American Thoracic Society (ATS) Task Force on severe asthma includes an updated definition of severe asthma, a discussion of severe asthma phenotypes in relation to genetics, natural history, pathobiology and p...
Global cardiovascular disease (CVD) burden is high and rising, especially in low-income and middle-income countries (LMICs). Focussing on 45 LMICs, we aimed to determine (1) the adult population’s median 10-year predicted CVD risk, including its v...
